Abstract
Abstract Efficacy and safety of various treatment regimens for asthma andchronic obstructive pulmonary disease (COPD) were hot topics atthe American College of Chest Physicians (CHEST) Annual Meeting.Numerous abstracts were presented that compared select long-termcontroller medications for the management of these pulmonary conditions.For COPD, data on withdrawing inhaled corticosteroids (ICS) inpatients with severe disease gained a lot of attention, as did robust datawith the use of tiotropium (Spiriva Respimat—Boehringer Ingelheim)for the management of asthma in pediatric and adult patients
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
